Please join us in congratulating Cleveland Clinic Lerner Research Institute's Angela Ting, PhD as she is co-leading a team of investigators at Fred Hutchinson Cancer Research Center and Cleveland Clinic who were recently awarded $1 million in medical research grant funding from the W.M. Keck Foundation. Dr. Ting is a member of the Case Comprehensive Cancer Center's GU Malignancies Program.
The team will use colorectal cancer as a model to determine if there is clear in vivo evidence of microbial restriction-modification enzymes interacting with human DNA and, if so, experimentally delineate the underlying molecular mechanism of such host-microbiota interactions.